|
|
|
|
|
|
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
A phase 2 trial of Gremubamab compared to placebo in participants with bronchiectasis and chronic Pseudomonas aeruginosa infection - 1-023-22
GRemubamab ErAdication Trial (GREAT-2) A phase 2 trial of gremubamab compared to placebo in participants with bronchiectasis and chronic Pseudomonas aeruginosa infection
A Phase 2 Proof-of-concept Study to Evaluate the Efficacy and Safety of MEDI3902 in Mechanically Ventilated Patients for the Prevention of Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa
Clinical trial looking to evaluate the efficacy and safety of MEDI3902 in mechanically ventilated participants for the prevention of nosocomial pneumonia caused by Pseudomonas aeruginosa.
100 Clinical Results associated with PslG x PcrV
100 Translational Medicine associated with PslG x PcrV
0 Patents (Medical) associated with PslG x PcrV